- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01468220
Normobaric Hypoxic Training and Metabolic Syndrome
March 1, 2019 updated by: Michael Boschmann, Charite University, Berlin, Germany
Normobaric Hypoxic Training Compared to Ambient Training on the Course of the Metabolic Syndrome
The patient numbers with metabolic syndrome and diabetes have doubled in the last decade.
Data that physical exercise ameliorates the metabolic syndrome are convincing, although the mechanisms of the effect in man are not clear.
Numerous endocrine or molecular mechanisms modified by physical exercise are known to be hypoxia-sensitive, i.e. by hypoxia-inducible factor-1 (HIF-1) regulation.
Thus, relative hypoxia may link physical exercise and modification of endogenous metabolism.
Medical communities seem ill equipped to address the primary issues involved.
The investigators have experience with normobaric "hypoxia chambers" and will now test a (physical exercise) training program, using state-of-the-art assessments available nowhere else in Germany.
The investigators will compare hypoxia chamber, to ambient training, to test the notion that specific exercise conditions could regulate specific molecular pathways involved in the pathogenesis of the metabolic syndrome.
Indeed, hypoxia chamber training could be superior to conventional training in terms of reducing cardiovascular risk factors or improving fitness.
The investigators will test overall metabolism-related effects with a metabolic chamber.
The investigators will test local metabolism with microdialysis during exercise routines, and the investigators will perform fat and muscle biopsies to investigate tissue-related effects.
The investigators include experience from a broad-ranging spectrum.
The investigators findings might improve understanding mechanisms linking physical exercise and endogenous metabolism.
Furthermore, they could influence decision-making regarding non-pharmacological interventions.
Study Overview
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 13125
- Charite University Medicine, ECRC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Body mass index 27-40 kg/m2
- Abdominal obesity (waist circumference >102 cm form men, >88 cm for women)
- Two further diagnostic criteria of metabolic syndrome (ATP III Definition):
- HDL cholesterin <40 mg/dl for men, <50 mg/dl for men
- Triglyceride >150 mg/dl
- Fasting glucose >110 mg/dl
- Blood pressure >135/80 mm Hg
- Less than 2 hours of physical activity per week
- Sinus rhythm
Exclusion Criteria:
- Other relevant metabolic or cardiovascular diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: normoxic training
6 weeks of endurance training under normoxia
|
Endurance training three times per week over six weeks
|
|
Active Comparator: hypoxic training
6 weeks of endurance training under hypoxia
|
Endurance training three times per week over six weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Increase in mitochondria number in skeletal muscle with exercise in hypoxia compared to normoxia
Time Frame: Participants will be followed for the duration of the training program, an expected average of 6 weeks
|
Participants will be followed for the duration of the training program, an expected average of 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
June 1, 2018
Study Registration Dates
First Submitted
September 15, 2011
First Submitted That Met QC Criteria
November 7, 2011
First Posted (Estimate)
November 9, 2011
Study Record Updates
Last Update Posted (Actual)
March 4, 2019
Last Update Submitted That Met QC Criteria
March 1, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Hypoxitrain 1
- Hypoximet 1 (Other Grant/Funding Number: DFG_LU_435_12/1)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Sun Yat-sen UniversityNot yet recruitingMetabolic Syndrome Risk Factors | Metabolic Syndrome (MetS)China
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityRecruiting
-
Meihua JiThe Luhe Teaching Hospital of the Capital Medical UniversityEnrolling by invitationMetabolic Syndrome (MetS)China
-
National University Health System, SingaporeRecruitingMetabolic Syndrome | Metabolic Syndrome (MetS)Singapore
-
University of KhartoumMinistry of Higher Education and Scientific Research, Republic of SudanCompletedMetabolic Syndrome in Postmenopausal FemalesSudan
-
Hacettepe UniversityCompletedMetabolic Syndrome | Metabolic Syndrome Obesity | Metabolic Syndrome ParametersTurkey
-
Universidad de los Andes, ChileCompleted
-
University of Missouri-ColumbiaRecruitingGlucose Metabolism Disorders | Metabolic Syndrome | Metabolic Syndrome, Protection AgainstUnited States
-
Mayo ClinicCompleted
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
Clinical Trials on Endurance training
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
General University Hospital, PragueRecruitingParkinson Disease, IdiopathicCzech Republic
-
Riphah International UniversityRecruitingHockey | Plyometric Exercise | Endurance TrainingPakistan
-
University Hospital HeidelbergDietmar Hopp Stiftung; Friederike Rosenberger (University Hospital Heidelberg)...Completed
-
University of ViennaCompletedCOVID-19 | Post-COVID-19 Syndrome | Long COVID-19Austria
-
Landsteiner InstitutLund University; Medical University of Vienna; Mein Hanusch-Krankenhaus; Fondazione... and other collaboratorsCompletedType 2 Diabetes Mellitus | Insulin ResistanceAustria
-
Universität des SaarlandesThe German Heart FoundationCompletedChronic Heart Failure | Dilated CardiomyopathyGermany
-
General Committee of Teaching Hospitals and Institutes...Cairo University; Taibah UniversityCompleted